Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • FrameworkLTC Reviews & Ratings
    4.4 out of 5 stars 48 Ratings
    Company Website for FrameworkLTC
  • CredentialStream Reviews & Ratings
    4.0 out of 5 stars 190 Ratings
    Company Website for CredentialStream
  • AthenaHQ Reviews & Ratings
    4.9 out of 5 stars 50 Ratings
    Company Website for AthenaHQ
  • D&B Risk Analytics Reviews & Ratings
    4.4 out of 5 stars 81 Ratings
    Company Website for D&B Risk Analytics
  • DialedIn Reviews & Ratings
    4.8 out of 5 stars 625 Ratings
    Company Website for DialedIn
  • 3D Cloud Reviews & Ratings
    4.7 out of 5 stars 42 Ratings
    Company Website for 3D Cloud
  • MikMak Reviews & Ratings
    4.5 out of 5 stars 85 Ratings
    Company Website for MikMak
  • Qloo Reviews & Ratings
    5.0 out of 5 stars 23 Ratings
    Company Website for Qloo
  • Fraud.net Reviews & Ratings
    4.6 out of 5 stars 56 Ratings
    Company Website for Fraud.net
  • Evertune Reviews & Ratings
    5.0 out of 5 stars 1 Rating
    Company Website for Evertune

What is DrugPatentWatch?

In the global biopharmaceutical industry, business intelligence centers around understanding the evolving dynamics of drug patents and the emergence of generic medications. Accurately predicting future financial requirements and actively identifying generic substitutes are crucial for sustained success. By examining the successes of former patent challengers, companies can gain valuable insights into the competitive environment and shape their research trajectories. This kind of analysis is essential for informing portfolio management strategies for upcoming drug development initiatives. Moreover, effectively anticipating when patents for branded medications will expire, identifying likely generic suppliers, and managing the inventory of branded drugs are critical tasks. In addition, obtaining comprehensive data on formulation and manufacturing enables the identification of pivotal formulators, repackagers, and relabelers, which can optimize operations and improve market positioning. Grasping these factors is vital, as it can lead to enhanced strategic decision-making, ultimately driving the biopharmaceutical sector toward innovation and growth. By leveraging this intelligence, companies can better navigate the complexities of the market to stay ahead of the competition.

What is Cytel?

Cytel is recognized as a leading global innovator in the realm of software dedicated to clinical trial design, biometrics, and sophisticated analytics, with a goal of enhancing clinical trial efficiency while empowering pharmaceutical firms to fully leverage both clinical and real-world data. Founded in 1987 by esteemed statisticians Cyrus Mehta and Nitin Patel, Cytel has maintained its position at the forefront of adaptive clinical trial technology and biostatistics. Its flagship software, the East Horizon platform, plays a crucial role in supporting accurate trial design and simulation, utilizing adaptive and Bayesian approaches to refine protocols and streamline the drug development journey. The East Horizon platform represents a holistic integration of Cytel's trusted software solutions, boasting R integration that markedly enhances trial design capabilities. Additionally, Cytel offers the Xact software suite, an extensive toolkit tailored for statistical analysis of smaller datasets, effectively addressing challenges posed by sparse and missing data. By persistently innovating and broadening its range of products, Cytel is dedicated to delivering state-of-the-art solutions that align with the dynamic demands of clinical research, ensuring that researchers have the tools necessary to improve patient outcomes. As a result, Cytel continues to shape the future of clinical trials through its unwavering commitment to excellence in software development and analytics.

Media

Media

Integrations Supported

Integrations Supported

R

API Availability

API Availability

Pricing Information

$250 per month
Free Version

Pricing Information

Pricing not provided
Free Trial Offered?

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Not specified

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

DrugPatentWatch

Date Founded

2003

Company Location

United States

Company Website

www.drugpatentwatch.com

Company Facts

Organization Name

Cytel

Date Founded

1987

Company Location

United States

Company Website

cytel.com

Categories and Features

Drug Discovery

Not specified

Categories and Features

Drug Discovery

Not specified

Life Sciences

Not specified

Popular Alternatives

Popular Alternatives

Healnet Reviews & Ratings

Healnet

Healx
Medidata Reviews & Ratings

Medidata

Dassault Systèmes
BIOiSIM Reviews & Ratings

BIOiSIM

VERISIMLife